Jointown(SH:600998) Quan Jing Wang·2025-11-04 07:57Core Viewpoint - 九州通's medical device segment showed strong growth in the first three quarters of 2025, with sales revenue reaching 28.963 billion yuan, a year-on-year increase of 17.20% [1] Group 1: Business Performance - The medical device business covers three main areas: OTC, medical, and professional services, demonstrating a diversified and collaborative development pattern [1] - In the OTC segment, 九州通 collaborated with well-known brands such as Yuyue, Sanor, Kefu Mei, and Durex, achieving comprehensive coverage across all categories and channels [1] - The online business saw significant growth due to the "old-for-new" policy for consumer goods, with related sales exceeding 537 million yuan in the first three quarters [1] Group 2: Medical Business - 九州通 focuses on high-value consumables in major surgical, vascular intervention, orthopedics, and IVD fields, establishing partnerships with over 60% of the global top 100 multinational companies and 80% of domestic top 100 industrial enterprises [1] - The sales revenue from medical equipment under the "old-for-new" policy reached 5 billion yuan, marking a 42% year-on-year increase [1] - The company accelerated the expansion of its SPD (Supply Processing Distribution) business, signing 28 new projects in the first three quarters, with a cumulative total of 132 bids won [1] Group 3: Professional Services - 九州通 continues to optimize its SPD system and digital service platforms such as the Orthopedic Chang'e platform, advancing the development of SPD smart cabinets [1] - The company achieved full tracking of personnel and goods in 3D trajectories, providing integrated supply chain solutions for hospitals [1]